CSH Innovation Forum| Jiang Qian, Liu Ligen, Xu Pengpeng, He Yang invite you to join the academic feast on September 23-25 - the 17th National Hematology Academic Conference of the Chinese Medical Association

Listening to the sound of blood and perceiving the rhythm of life, the much-anticipated "17th National Hematology Academic Conference of the Chinese Medical Association" will be grandly opened
on September 23-25, 2022 at the National Convention and Exhibition Center in Shanghai.
The conference was hosted by the Chinese Medical Association and the Hematology Branch of the Chinese Medical Association, hosted by the Shanghai Medical Association, co-organized by Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the First Affiliated Hospital of Soochow University, and the Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, with the theme of "respect, inheritance, collaboration and innovation", specially invited famous experts at home and abroad to talk about the latest progress
in the field of blood diseases.

CML Forum

September 24 13:00-18:00

Professor Jiang Qian

Peking University People's Hospital

Distinguished leaders, experts, teachers, hello
.
It is a great honor to be invited to host the 17th National Hematology Academic Conference of the Chinese Medical Association - Chronic Myeloid Leukemia (CML) Forum
on the occasion of the 922 International Slow Grain Day.
At present, most patients with slow granules can benefit from the treatment of albonine kinase inhibitors (TKI), but there are still many unsolved problems in the CML field, such as drug resistance, discontinuation and other issues
.
At this conference, we invited a number of well-known experts at home and abroad to exchange views on the hot topics of CML and share their work
on TKI drug resistance, dose reduction and drug discontinuation.
It is hoped to improve the overall treatment and management level of CML in China, so that more patients can achieve precise targeted treatment and personalized treatment, and improve the survival and quality
of life of patients.
Hereby, we would like to express our heartfelt thanks to all the experts who participated in this CML Forum and wish this conference a complete success
.

MDT forum for difficult cases

September 24 13:30-17:30

Professor Liu Ligen

Tongren Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Distinguished colleagues, hello
.
It is a great honor to be responsible for the preparation of the 17th National Hematology Academic Conference of the Chinese Medical Association - MDT Forum for Difficult Cases
.
There are many types of blood diseases, no specific clinical manifestations, complex and changeable conditions, and the diagnosis and treatment are challenging
.
As a hematology doctor, it is an indescribable enjoyment
to successfully diagnose and treat difficult cases, and then review the diagnosis and treatment process, communicate with the master, and experience the "magic tricks" in diagnosis and treatment.
Diseases of the lymphatic system are common diseases of the blood system and are tricky
to treat.
With the wide application of MICM typing in hematological tumor diseases, precision diagnosis and treatment and individualized diagnosis and treatment have been more realized in the clinic; The development and application of new technologies such as immunochemotherapy, gene therapy, and immune cell therapy have made rapid progress in the diagnosis and treatment of hematological tumors, and hematology doctors have successfully treated more and more patients with difficult and complex blood diseases, and experienced more and more sense of
accomplishment.
The MDT forum of difficult cases of this conference invited 3 domestic TOP-level blood disease diagnosis and treatment teams to share the experience of diagnosis and treatment of difficult cases of lymphatic system encountered in clinical practice, and invited 39 domestic TOP-level hematology experts to participate in comments and discussions, and invited experts to enjoy this "difficult to overcome" conference
.
I wish the conference a complete success!

R&D pipeline forum

September 24 13:30-17:30

Professor Xu Pengpeng

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Transforming new molecular targets in the laboratory into targeted drugs that can be used in clinical applications for the benefit of patients is the direction of the joint efforts of
hematology colleagues and pharmaceutical companies.
In recent years, a large number of innovative drugs have emerged in China, making great contributions
to improving people's health and practicing the healthy China strategy.
The R&D pipeline forum of the conference specially invited the heads of R&D pipelines of top innovative pharmaceutical companies in China to share the most cutting-edge R&D results and clinical research data for everyone to promote the development of
domestic innovative drugs.
R&D pipeline forum looks forward to your arrival!

EBMT/Nursing Forum

September 24 14:00-18:30

Hao Yang Nursing Supervisor

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Hello
experts and nursing colleagues.
The European Society for Blood and Marrow Transplantation (EBMT)/Nursing Forum is the first academic feast focusing on hematological nursing in China and Europe, and will conduct in-depth discussions
on cutting-edge topics such as the current situation of hematopoietic stem cell transplantation care in China and Europe, and the care of hematopoietic stem cell transplantation complications.
The holding of this forum will open a new chapter
in the mutual learning of hematological nursing between China and Europe, the in-depth exchange of nursing management at home and abroad, and the innovative nursing practice.
We sincerely invite you to participate in the vigorous development of the cause of hematology nursing!

September 23-25

The 17th National Conference on Hematology of the Chinese Medical Association

Respect, heritage, collaboration, innovation

Welcome to Shanghai!